Seeking Alpha

Caraco Pharmaceutical Labortories Ltd. (CPD)

()

News & PR
Market Currents

Buzz
Twitter: CPD

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on CPD

Caraco Update by Pakiya
Today Caraco announced they have reached a consent decree with the FDA. From the announcement: Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug... More »
September 30, 2009 • CPD
Caraco - Underappreciated and Undervalued by Pakiya
Investment Thesis Caraco has annual $350M in sales and $32M in net income. The company has almost no CapEx, and over $45 in net cash. The company sells for a market cap of $116M and an EV of $70M, an EV-to-earnings multiple of 2x. The management has publicly stated a 25% sales growth for FY 2009... More »
August 4, 2009 • CPD
Contrarian Stock Screen: Biggest Losers in 2009 (deleveraged & profitable companies) by The Manual of Ideas
One of the favorite screening methods of contrarian investors is to search for companies whose stock prices have underperformed the broader market. In the screen presented below, we highlight stocks that have underperformed year-to-date in 2009 (through July 10th).In order to minimize the... More »
July 11, 2009 • BEAT, VPHM, ENER
Russell's U.S. indexes move healthcare stocks - CXM, CTIC, HEB, and CPD by M. E. Garza
When Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes, especially it's broad-market Russell 3000 Index, stocks move. That is certainly the story for biomedical stocks as regular hours trading came to a close on Friday. Today, the annual reconstitution of... More »
June 26, 2009 • CTIC, HEB, DNDN
FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, H. Lundbeck by Mike Havrilla
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch... More »
June 25, 2009 • HLUKY.PK, CPD, INSM
Caraco Pharma (AMEX:CPD): Poised for a Turnaround by Mike Havrilla
On 5/28/09, Caraco Pharma (AMEX:CPD) reported its fiscal year 2009 (FY09) results and provided an update on the status of a recently completed FDA inspection of the Company's manufacturing facilities in Detroit, MI. Net sales for CPD declined by 4% for FY09 to a level of $337.2M (versus $350.4M... More »
May 30, 2009 • CPD, MYL, HITK
BioMedReports.com Most Popular Articles, Reports by Mike Havrilla
The following are links to the most viewed articles and stock research reports at BioMedReports.com since the site was launched earlier this year:Stock Research Reports - Cytori Therapeutics (CYTX), NIVS IntelliMedia... More »
April 9, 2009 • CPD, MNTA, EXAS

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Caraco Pharmaceutical Labortories Ltd. (CPD)

Instablog posts on CPD

Caraco Update by Pakiya

Caraco - Underappreciated and Undervalued by Pakiya

Contrarian Stock Screen: Biggest Losers in 2009 (deleveraged & profitable companies) by The Manual of Ideas

Russell's U.S. indexes move healthcare stocks - CXM, CTIC, HEB, and CPD by M. E. Garza

FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, H. Lundbeck by Mike Havrilla

Caraco Pharma (AMEX:CPD): Poised for a Turnaround by Mike Havrilla

BioMedReports.com Most Popular Articles, Reports by Mike Havrilla

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers